Intervention with insulin and tumor necrosis factor-α (TNFα) as well as stearic acid (a saturated free fatty acid) upregulate RELMβ expression, while D-glucose downregulates RELMβ in human colon cancer cells [33]. The gene discussed is RETNLB; the disease is colonic neoplasm.